CSU secures $3.1 million from NIH to advance SolaVAX coronavirus vaccine research

CSU secures $3.1 million from NIH to advance SolaVAX coronavirus vaccine research

FORT COLLINS -- A team of scientists at Colorado State University was awarded a base contract worth $3.1 million from the National Institutes of Health to continue development... Read More

Tuesday September 22, 2020 0 comments Tags: Fort Collins, CSU, COVID-19, NIH, SolaVAX, Ray Goodrich, CSU Infectious Disease Research Center , CSU BioMARC

CSU secures award from U.S. government for development of SolaVAX vaccine manufacturing process for SARS-CoV-2

CSU secures award from U.S. government for development of SolaVAX vaccine manufacturing process for SARS-CoV-2

FORT COLLINS -- A team of infectious disease researchers at Colorado State University has entered into an agreement with the Biomedical Advanced Research and Development Authority ... Read More

Friday June 26, 2020 0 comments Tags: Fort Collins, CSU, Alan Rudolph, Ray Goodrich, BARDA

CSU researchers pursue a vaccine to target Achilles heel of coronavirus

CSU researchers pursue a vaccine to target Achilles heel of coronavirus

FORT COLLINS -- Propelled by the COVID-19 pandemic, a Colorado State University research team is pursuing a vaccine that would thwart the novel coronavirus using a genetically... Read More

Monday April 6, 2020 0 comments Tags: Fort Collins, CSU, COVID-19, Gregg Dean, Allison Vilander, Alan Rudolph, Sue VandeWoude, Ray Goodrich

Zoetis to create research lab at CSU to target livestock immunotherapies as alternative to antibiotics

Zoetis to create research lab at CSU to target livestock immunotherapies as alternative to antibiotics

FORT COLLINS -- New Jersey-based Zoetis , a leading global animal health company, announced it has signed an agreement with Colorado State University to establish a... Read More

Tuesday July 30, 2019 0 comments Tags: Fort Collins, CSU, Zoetis, Ray Goodrich

Immunology Summit highlights advances in cell therapy, challenges that remain to be overcome

Immunology Summit highlights advances in cell therapy, challenges that remain to be overcome

By Steve Porter InnovatioNews Editor LOVELAND -- Ongoing advances in immunotherapies are making great strides treating those in clinical studies stricken with cancer and other... Read More

By: steveporter Friday August 17, 2018 0 comments Tags: Loveland, 2018 Immunology Summit, Ray Goodrich, Steven Schuster, Harvey Klein, Enkhee Purev, NoCoBio, Innosphere

Terumo BCT receives $17.4M contract from BARDA for blood study

Terumo BCT receives $17.4M contract from BARDA for blood study

LAKEWOOD -- Terumo BCT , a global medical device manufacturing company, announced it has been awarded $17.4 million in initial funding from the Biomedical Advanced Research and Development... Read More

Thursday June 23, 2016 0 comments Tags: Terumo BCT, Lakewood, BARDA, Mirasol Pathogen Reduction Technology, Ray Goodrich